Primary |
Diabetes Insipidus |
30.1% |
Enuresis |
15.4% |
Product Used For Unknown Indication |
8.9% |
Hypopituitarism |
7.2% |
Hypertension |
4.8% |
Nocturia |
4.8% |
Von Willebrand's Disease |
4.1% |
Depression |
2.7% |
Drug Use For Unknown Indication |
2.7% |
Diabetes Mellitus |
2.4% |
Vitamin Supplementation |
2.4% |
Type 2 Diabetes Mellitus |
2.1% |
Benign Prostatic Hyperplasia |
1.7% |
Bladder Disorder |
1.7% |
Congestive Cardiomyopathy |
1.7% |
Dental Implantation |
1.7% |
Bleeding Time Prolonged |
1.4% |
Central Diabetes Insipidus |
1.4% |
Coronary Artery Disease |
1.4% |
Dry Mouth |
1.4% |
|
Drug Ineffective |
17.6% |
Hyponatraemia |
11.8% |
Water Intoxication |
10.1% |
Thirst |
5.9% |
Urine Output Increased |
5.9% |
Vomiting |
5.0% |
Overdose |
4.2% |
Pharmaceutical Product Complaint |
4.2% |
Drug Effect Decreased |
3.4% |
Headache |
3.4% |
Inappropriate Antidiuretic Hormone Secretion |
3.4% |
Rash |
3.4% |
Vena Cava Thrombosis |
3.4% |
Weight Increased |
3.4% |
Blood Sodium Decreased |
2.5% |
Brain Oedema |
2.5% |
Convulsion |
2.5% |
Nausea |
2.5% |
Pollakiuria |
2.5% |
Pulmonary Embolism |
2.5% |
|
Secondary |
Diabetes Insipidus |
13.1% |
Obsessive-compulsive Disorder |
9.7% |
Enuresis |
9.2% |
Hypertension |
6.3% |
Product Used For Unknown Indication |
6.3% |
Hypopituitarism |
5.8% |
Diabetes Mellitus |
4.9% |
Drug Use For Unknown Indication |
4.9% |
Benign Prostatic Hyperplasia |
4.4% |
Von Willebrand's Disease |
4.4% |
Depression |
3.9% |
Hormone Replacement Therapy |
3.9% |
Ill-defined Disorder |
3.4% |
Central Diabetes Insipidus |
2.9% |
Convulsion |
2.9% |
Coronary Artery Disease |
2.9% |
Hypertonic Bladder |
2.9% |
Lung Adenocarcinoma |
2.9% |
Nocturia |
2.9% |
Dental Implantation |
2.4% |
|
Hyponatraemia |
14.3% |
Water Intoxication |
14.3% |
Urine Output Increased |
9.1% |
Drug Ineffective |
7.8% |
Vomiting |
7.8% |
Headache |
5.2% |
Hypouricaemia |
3.9% |
Nausea |
3.9% |
Urine Output Decreased |
3.9% |
Wrong Drug Administered |
3.9% |
Basophil Count Increased |
2.6% |
Drug Hypersensitivity |
2.6% |
Facial Paresis |
2.6% |
Hypochloraemia |
2.6% |
Incontinence |
2.6% |
Intracardiac Thrombus |
2.6% |
Jaundice |
2.6% |
Pain |
2.6% |
Pulmonary Embolism |
2.6% |
Pulseless Electrical Activity |
2.6% |
|
Concomitant |
Product Used For Unknown Indication |
30.8% |
Drug Use For Unknown Indication |
27.3% |
Hypopituitarism |
7.9% |
Growth Hormone Deficiency |
5.5% |
Diabetes Insipidus |
3.5% |
Osteoporosis |
2.6% |
Hypertension |
2.0% |
Hypothyroidism |
2.0% |
Blood Antidiuretic Hormone Decreased |
1.8% |
Ill-defined Disorder |
1.7% |
Bladder Disorder |
1.6% |
Adrenal Insufficiency |
1.5% |
Prophylaxis |
1.5% |
Blood Follicle Stimulating Hormone Decreased |
1.5% |
Blood Luteinising Hormone Decreased |
1.5% |
Constipation |
1.5% |
Depression |
1.5% |
Hypogonadism |
1.5% |
Blood Corticotrophin Decreased |
1.4% |
Rheumatoid Arthritis |
1.4% |
|
Vomiting |
16.0% |
Neoplasm Recurrence |
12.3% |
Craniopharyngioma |
6.1% |
Death |
5.5% |
Muscle Spasms |
4.9% |
Progressive Multifocal Leukoencephalopathy |
4.9% |
Sepsis |
4.9% |
Weight Decreased |
4.9% |
Hypernatraemia |
4.3% |
Renal Failure |
4.3% |
Pituitary Tumour Benign |
3.7% |
Somnolence |
3.7% |
White Blood Cell Count Increased |
3.7% |
Epiphysiolysis |
3.1% |
Infection |
3.1% |
Malignant Melanoma |
3.1% |
Renal Failure Acute |
3.1% |
Urinary Tract Infection |
3.1% |
Weight Increased |
3.1% |
Arthropathy |
2.5% |
|
Interacting |
Hypothalamo-pituitary Disorder |
15.8% |
Analgesic Therapy |
10.5% |
Depression |
10.5% |
Enuresis |
10.5% |
Hypercholesterolaemia |
10.5% |
Brain Neoplasm |
5.3% |
Convulsion |
5.3% |
Diabetes Insipidus |
5.3% |
Drug Use For Unknown Indication |
5.3% |
Epilepsy |
5.3% |
Gastritis Prophylaxis |
5.3% |
Hypopituitarism |
5.3% |
Migraine |
5.3% |
|
Hyponatraemia |
33.3% |
Depressed Level Of Consciousness |
16.7% |
Loss Of Consciousness |
16.7% |
Vomiting |
16.7% |
Water Intoxication |
16.7% |
|